Insmed
INSM
#542
Rank
ยฃ32.65 B
Marketcap
ยฃ153.13
Share price
-0.51%
Change (1 day)
159.37%
Change (1 year)

Insmed (INSM) - Cash on Hand

Cash on Hand as of September 2025 : ยฃ1.26 Billion

According to Insmed's latest financial reports the company has ยฃ1.26 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Insmed - Cash on Hand chart (from 2000 to 2025)

Cash on Hand by year

Year Cash on Hand Change
2024-12-31ยฃ1.14 B86.51%
2023-12-31ยฃ0.61 B-35.46%
2022-12-31ยฃ0.94 B78.74%
2021-12-31ยฃ0.53 B35.86%
2020-12-31ยฃ0.39 B5.15%
2019-12-31ยฃ0.37 B-4.69%
2018-12-31ยฃ0.39 B38.29%
2017-12-31ยฃ0.28 B114.03%
2016-12-31ยฃ0.13 B-30.97%
2015-12-31ยฃ0.19 B86.65%
2014-12-31ยฃ0.10 B48.12%
2013-12-31ยฃ69.04 M20.08%
2012-12-31ยฃ57.49 M17.17%
2011-12-31ยฃ49.07 M-29.89%
2010-12-31ยฃ69.99 M-7.3%
2009-12-31ยฃ75.5 M4516.59%
2008-12-31ยฃ1.63 M-80.28%
2007-12-31ยฃ8.29 M-32.61%
2006-12-31ยฃ12.3 M12.7%
2005-12-31ยฃ10.92 M127.38%
2004-12-31ยฃ4.8 M-70.9%
2003-12-31ยฃ16.5 M-3.19%
2002-12-31ยฃ17.04 M-51.77%
2001-12-31ยฃ35.34 M-36.5%
2000-12-31ยฃ55.66 M1840.61%
1999-12-31ยฃ2.86 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Sarepta Therapeutics
SRPT
ยฃ0.63 B-49.35%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
ยฃ7.32 B 480.54%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Gilead Sciences
GILD
ยฃ5.51 B 337.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Array Technologies
ARRY
ยฃ0.16 B-86.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Aerie Pharmaceuticals
AERI
ยฃ0.12 B-89.73%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
ยฃ4.71 B 274.23%๐Ÿ‡บ๐Ÿ‡ธ USA